Test Name:
Prospera (TAT 7 working days)
Specialised Test:
No - Send Out Test
Additional Test Note:
The Prospera transplant assessement evaluates the level of donor-derived cell-free DNA (dd-cfDNA) in the kidney transplant recipient’s blood, which strongly correlates with acute rejection and other types of kidney injury. Other organs include Heart and Lung.
Prospera is a transplant rejection assessment test that requires peripheral blood drawn to evaluate the risk of rejection in a recipient. It increases a provider�s ability to identify otherwise undetected rejection. A comprehensive view of patient�s rejection status: providers could improve their post-transplant rejection assessments frequently as and when needed without invasive procedures. For details, refer to website: https://www.natera.com/organ-health/prospera-organ-transplantation- assessment/
Sample Requirement:
2 x 10 ml Whole blood in DNA Streck tubes provided in the Prospera collection kit
Parkway Laboratory Services